Oglionucleotide Cards
N0017326Q5252 · DEPT OF DEFENSE
A IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING solicitation, performed in Washington, DC, with responses due 2026-06-24. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
NOTICE OF INTENT TO AWARD A SOLE SOURCE This Notice of Intent is not a request for competitive proposals. This is not a solicitation or request for offers. Only one responsible source and no other supplies or services will satisfy agency requirements. The Naval Research Laboratory (NRL) intends to a
Comparable recent awards in IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| REMEL INC. | $64K | n/a | 2026-07-02 |
| CEPHEID | $306K | n/a | 2026-07-01 |
| ABBOTT LABORATORIES INC. | $102K | 1 | 2026-07-01 |
| ROCHE DIAGNOSTICS CORPORATION | $615K | 1 | 2026-07-01 |
| ABBOTT LABORATORIES INC. | $2.8M | n/a | 2026-07-01 |
Questions
What is solicitation N0017326Q5252?
Oglionucleotide Cards, issued by DEPT OF DEFENSE, under NAICS 325413 (IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING), performed in Washington, DC. Responses are due 2026-06-24.
What do similar contracts close for?
Comparable closed awards in this category ran from $64K to $2.8M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Is N0017326Q5252 set aside?
NONE. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.